Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keverprazan vs Quadruple Therapy for H. pylori Rescue
NCT06760065Phase 3Not yet recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of keverprazan in Helicobacter pylori infection, sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
keverprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06760065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06760065.